Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche divulges new cGAS inhibitors

Dec. 13, 2021

TYK Medicines patents RET inhibitors

Dec. 13, 2021

AG-01 shows antitumor efficacy in models of triple-negative breast cancer

Dec. 13, 2021

CHMP7 as therapeutic target in sporadic and C9orf72 ALS

Dec. 13, 2021

NextVivo launches to develop immune organoid technology platform

Dec. 10, 2021

CRISPR-Cas9 gRNA system eliminates diverse proviral HIV-1 strains

Dec. 10, 2021

Totus receives financing to advance TOS-358 drug program for cancer

Dec. 10, 2021

BetterLife's TD-0148A reverses depressive-like behavior in chronically stressed mice

Dec. 10, 2021

MDX-124 shows efficacy in preclinical models of TNBC

Dec. 10, 2021

lncRNA XIST could be used to select triple-negative breast cancer patients for ERbeta therapy

Dec. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...